Detalhe da pesquisa
1.
TGFBR1 and cancer susceptibility.
Trans Am Clin Climatol Assoc
; 125: 300-12, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25125747
2.
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.
Chin J Cancer
; 32(11): 573-81, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24206915
3.
TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects.
NPJ Breast Cancer
; 8(1): 84, 2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853889
4.
Lynch Syndrome Testing: A Missed Opportunity in the Era of Precision Medicine.
JAMA
; 316(1): 38-9, 2016 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380341
5.
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2â¯T-type voltage-gated calcium channels and Ca2+ influx.
EBioMedicine
; 44: 209-224, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160272
6.
Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583.
Cancer Genet
; 205(1-2): 25-33, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22429595
7.
Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.
J Exp Clin Cancer Res
; 29: 57, 2010 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20500843
8.
Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer.
Science
; 321(5894): 1361-5, 2008 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18703712